Free Trial

BriaCell Therapeutics (BCTXW) SEC Filings & 10K Form

BriaCell Therapeutics logo
$0.04 +0.01 (+20.60%)
Closing price 10/8/2025 03:59 PM Eastern
Extended Trading
$0.06 +0.02 (+35.06%)
As of 07:21 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent BriaCell Therapeutics SEC Filings

DateFilerForm TypeView
08/25/2025
7:18 PM
BriaCell Therapeutics Corp. (Filer)
BriaCell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/28/2025
10:38 AM
BriaCell Therapeutics Corp. (Subject)
BriaCell Therapeutics (Subject)
Iroquois Capital Management, LLC (Filed by)
Form SCHEDULE 13G
07/21/2025
10:16 AM
BriaCell Therapeutics Corp. (Subject)
BriaCell Therapeutics (Subject)
CVI Investments, Inc. (Filed by)
Form SCHEDULE 13G/A
07/16/2025
3:15 PM
BriaCell Therapeutics Corp. (Filer)
BriaCell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/15/2025
8:18 PM
BriaCell Therapeutics Corp. (Filer)
BriaCell Therapeutics (Filer)
Form 424B4
07/15/2025
11:15 PM
BriaCell Therapeutics Corp. (Filer)
BriaCell Therapeutics (Filer)
Form EFFECT
07/10/2025
4:29 PM
BriaCell Therapeutics Corp. (Filer)
BriaCell Therapeutics (Filer)
Form S-1/A
07/09/2025
12:05 PM
BriaCell Therapeutics Corp. (Filer)
BriaCell Therapeutics (Filer)
Form S-1/A
07/08/2025
3:46 PM
BriaCell Therapeutics Corp. (Subject)
BriaCell Therapeutics (Subject)
Form FWP
07/08/2025
3:08 PM
BriaCell Therapeutics Corp. (Filer)
BriaCell Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
06/18/2025
7:27 AM
BriaCell Therapeutics Corp. (Filer)
BriaCell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/16/2025
3:34 PM
BriaCell Therapeutics Corp. (Filer)
BriaCell Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/13/2025
8:08 PM
3i, LP (Filed by)
BriaCell Therapeutics Corp. (Subject)
BriaCell Therapeutics (Subject)
Form SCHEDULE 13G/A
05/01/2025
9:01 AM
BriaCell Therapeutics Corp. (Subject)
BriaCell Therapeutics (Subject)
CVI Investments, Inc. (Filed by)
Form SCHEDULE 13G
04/28/2025
3:15 PM
BriaCell Therapeutics Corp. (Filer)
BriaCell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/28/2025
8:06 AM
BriaCell Therapeutics Corp. (Filer)
BriaCell Therapeutics (Filer)
Form 424B4
04/28/2025
8:07 AM
BriaCell Therapeutics Corp. (Filer)
BriaCell Therapeutics (Filer)
Form 424B4
04/24/2025
11:15 PM
BriaCell Therapeutics Corp. (Filer)
BriaCell Therapeutics (Filer)
Form EFFECT
04/24/2025
4:11 PM
BriaCell Therapeutics Corp. (Filer)
BriaCell Therapeutics (Filer)
Form S-1MEF
04/24/2025
3:41 PM
BriaCell Therapeutics Corp. (Filer)
BriaCell Therapeutics (Filer)
Form CERT
04/24/2025
2:46 PM
BriaCell Therapeutics Corp. (Filer)
BriaCell Therapeutics (Filer)
Form 8-A12B
04/23/2025
3:51 PM
BriaCell Therapeutics Corp. (Filer)
BriaCell Therapeutics (Filer)
Form S-1/A
04/22/2025
3:26 PM
BriaCell Therapeutics Corp. (Subject)
BriaCell Therapeutics (Subject)
Form FWP
02/10/2025
8:02 PM
3i, LP (Filed by)
BriaCell Therapeutics Corp. (Subject)
BriaCell Therapeutics (Subject)
Form SCHEDULE 13G
02/06/2025
3:30 PM
BriaCell Therapeutics Corp. (Filer)
BriaCell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2025
4:02 PM
BriaCell Therapeutics Corp. (Filer)
BriaCell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2025
3:05 PM
BriaCell Therapeutics Corp. (Filer)
BriaCell Therapeutics (Filer)
Form 424B5
02/03/2025
3:37 PM
BriaCell Therapeutics Corp. (Filer)
BriaCell Therapeutics (Filer)
Form 424B5
12/17/2024
3:05 PM
BriaCell Therapeutics Corp. (Filer)
BriaCell Therapeutics (Filer)
Form DEF 14A
12/13/2024
3:15 PM
BriaCell Therapeutics Corp. (Filer)
BriaCell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2024
4:27 PM
BriaCell Therapeutics Corp. (Filer)
BriaCell Therapeutics (Filer)
Form 424B5
12/12/2024
5:06 AM
BriaCell Therapeutics Corp. (Subject)
BriaCell Therapeutics (Subject)
L5 Capital Inc. (Filed by)
Form SC 13D/A
12/11/2024
4:21 PM
BriaCell Therapeutics Corp. (Filer)
BriaCell Therapeutics (Filer)
Form 424B5
12/10/2024
5:06 AM
BriaCell Therapeutics Corp. (Subject)
BriaCell Therapeutics (Subject)
L5 Capital Inc. (Filed by)
Form SC 13D/A
12/05/2024
6:45 AM
BriaCell Therapeutics Corp. (Subject)
BriaCell Therapeutics (Subject)
L5 Capital Inc. (Filed by)
Form SC 13D/A
11/14/2024
11:17 AM
BriaCell Therapeutics Corp. (Subject)
BriaCell Therapeutics (Subject)
CVI Investments, Inc. (Filed by)
Form SC 13G/A
11/01/2024
3:05 PM
BriaCell Therapeutics Corp. (Filer)
BriaCell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:BCTXW) was last updated on 10/9/2025 by MarketBeat.com Staff
From Our Partners